1Niederman MS;Mandell LA;Anzueto A.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention,2001(07).
2Felmingham D;Grüneberg RN.The Alexander Project 1996-1997:latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections[J],2000.
3Song JH;Lee NY;Ichiyama S.Spread of drug-resistant Streptococcus pneumoniae in Asian countries:Asian network for suiveillance of resistant pathogens(ANSO-RP) study,1999(28).
4Bartlett JG;Breiman RF;Mandell LA.Community-acquired pneumonia in adults:guidelines for management[J],1998(4).
5Heffelfinger JD;Dowell SF;Jorgensen JH.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group,2000.
7Pfaller MA;Jones RN.Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection(MYSTIC) Programme,Europe 1997-2000[J],2002(19).
